Skip to main content
SLU:s publikationsdatabas (SLUpub)

Sammanfattning

Nineteen lipophilic thymidine phosphate-mimicking compounds were designed and synthesized as potential inhibitors of thymidine monophosphate kinase of Bacillus anthracis, a Gram-positive bacterium that causes anthrax. These thymidine analogues were substituted at the 5'-postion with sulfonamide-, amide-, (thio)urea-, or triazole groups, which served as lipophilic surrogates for phosphate. Three of the tested compounds produced inhibition of B. anthracis Sterne growth and/or thymidine monophosphate activity. Additional studies will be necessary to elucidate the potential of this type of B. anthracis thymidine monophosphate inhibitors as novel antibiotics in the treatment Of anthrax.

Nyckelord

bacillus anthracis thymidine monophosphate kinase (BaTMPK); 5'-modified; thymidine-based BaTMPK kinase inhibitors

Publicerad i

Nucleosides, Nucleotides and Nucleic Acids
2008, volym: 27, nummer: 3, sidor: 244-260
Utgivare: TAYLOR & FRANCIS INC

SLU författare

Globala målen (SDG)

SDG3 God hälsa och välbefinnande

UKÄ forskningsämne

Veterinärmedicin
Husdjursvetenskap

Publikationens identifierare

  • DOI: https://doi.org/10.1080/15257770701845238

Permanent länk till denna sida (URI)

https://res.slu.se/id/publ/20801